On The Pen: The Weekly Dose 7.2.24

Get OTP Emails: https://www.onthepen.com/emails

Eli Lilly

• Eli Lilly sent cease and desist letters to providers of research grade GLP-1s
• Exclusive news from onthepen.com that has not been covered by any other source
• https://www.onthepen.com/post/generic-versions-of-zepbound-how-recent-news-affects-their-future

Him & Hers:

• Him & Hers giving GLP medications without consulting with a doctor
• https://hntrbrk.com/hims/

Price for generic liraglutide/Victoza (multiple tiktok videos):

• Note: podcast last week announced generic liraglutide from Tera Pharma
• Prices as low as $225 for two pens
• https://www.goodrx.com/liraglutide?form=carton&dosage=2-pens-of-18mg-3ml&quantity=1&label_override=liraglutide

TROA

• Scaled-back TROA bill is passed out of the US House Ways and Means Committee 
• This version would limit coverage to people who had been taking a weight loss drug for a year prior to enrolling in Medicare
• https://www.nbcnews.com/health/health-news/house-committee-passes-bill-allow-medicare-cover-weight-loss-drugs-rcna159248

BI 3034701 (tiktok video):

• Boehringer Ingelheim and Gubra start phase 1 trial of BI 3034701 which is retatrutide competitor (GLP-1/GIP/glucagon)
• https://www.boehringer-ingelheim.com/science-innovation/human-health-innovation/phase-1-start-novel-triple-agonist-obesity-treatment

Onthepen.TV